Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination

Natalia S. Mattan, Cristina A. Ghiani, Marcia Lloyd, Reuben Matalon, Dean Bok, Patrizia Casaccia, Jean de Vellis

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.

Original languageEnglish (US)
Pages (from-to)432-443
Number of pages12
JournalNeurobiology of Disease
Volume40
Issue number2
DOIs
StatePublished - Nov 2010

Fingerprint

Canavan Disease
Oligodendroglia
Myelin Proteins
Enzymes
Neurodegenerative Diseases
Histones
Chromatin
Brain

Keywords

  • Aspartoacylase
  • Canavan disease
  • Development
  • Leukodystrophy
  • Neural cells
  • Oligodendrocytes

ASJC Scopus subject areas

  • Neurology

Cite this

Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. / Mattan, Natalia S.; Ghiani, Cristina A.; Lloyd, Marcia; Matalon, Reuben; Bok, Dean; Casaccia, Patrizia; de Vellis, Jean.

In: Neurobiology of Disease, Vol. 40, No. 2, 11.2010, p. 432-443.

Research output: Contribution to journalArticle

Mattan, Natalia S. ; Ghiani, Cristina A. ; Lloyd, Marcia ; Matalon, Reuben ; Bok, Dean ; Casaccia, Patrizia ; de Vellis, Jean. / Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. In: Neurobiology of Disease. 2010 ; Vol. 40, No. 2. pp. 432-443.
@article{d9b6065cd8094a9590aa525f0da30e16,
title = "Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination",
abstract = "Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.",
keywords = "Aspartoacylase, Canavan disease, Development, Leukodystrophy, Neural cells, Oligodendrocytes",
author = "Mattan, {Natalia S.} and Ghiani, {Cristina A.} and Marcia Lloyd and Reuben Matalon and Dean Bok and Patrizia Casaccia and {de Vellis}, Jean",
year = "2010",
month = "11",
doi = "10.1016/j.nbd.2010.07.003",
language = "English (US)",
volume = "40",
pages = "432--443",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination

AU - Mattan, Natalia S.

AU - Ghiani, Cristina A.

AU - Lloyd, Marcia

AU - Matalon, Reuben

AU - Bok, Dean

AU - Casaccia, Patrizia

AU - de Vellis, Jean

PY - 2010/11

Y1 - 2010/11

N2 - Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.

AB - Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.

KW - Aspartoacylase

KW - Canavan disease

KW - Development

KW - Leukodystrophy

KW - Neural cells

KW - Oligodendrocytes

UR - http://www.scopus.com/inward/record.url?scp=79958003786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958003786&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2010.07.003

DO - 10.1016/j.nbd.2010.07.003

M3 - Article

VL - 40

SP - 432

EP - 443

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 2

ER -